Skip to main content
SLS
NASDAQ Life Sciences

Sellas Prices $150M Offering at $13, a 28% Discount to Tuesday's Close

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$17.98
Mkt Cap
$3.659B
52W Low
$1.39
52W High
$24.89
52W Position info
1194% above low
Off High info
28% below high
Rel. Volume info
3.9× avg
Market data snapshot near publication time

SLS has more than doubled off its 52-week low of $1.39 on elevated volume (3.9× avg).

Summary

Sellas priced its $150M underwritten offering at $13.00 a share for 11,538,462 shares, a steep discount to the $17.98 last price. Underwriters have an option to buy 1.7M additional shares, and the company expects the offering to close Nov. 20. The raise follows Tuesday's 156% surge after the Phase 3 REGAL trial of galinpepimut-S met its primary overall survival endpoint, and it comes despite the company reporting $134.7M in cash at Q3, enough for at least twelve months. The discount reflects underwriters pricing in the post-spike volatility and the size of the deal relative to the float. The offering was launched Nov 17 with a 30-day option for up to $22.5M more; pricing at $13 is the key term traders now have.

At the time of this announcement, SLS was trading at $17.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $1.39 to $24.89. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

SLS - Latest Insights

SLS
Nov 18, 2026, 12:03 AM EST
Source: CNBC TV18
Importance Score:
7
Price at Filing: $17.14
Real-time Price: $14.29 info
Change: -$2.85 (-17%) info
Market Cap: $3.659B info
SLS
Nov 17, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.03
Real-time Price: $14.29 info
Change: -$3.74 (-21%) info
Market Cap: $3.659B info
SLS
Nov 17, 2026, 10:09 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $20.45
Real-time Price: $14.29 info
Change: -$6.16 (-30%) info
Market Cap: $3.659B info
SLS
Nov 17, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
10
Price at Filing: $8.00
Real-time Price: $14.29 info
Change: +$6.29 (+79%) info
Market Cap: $3.659B info
SLS
Nov 12, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.01
Real-time Price: $14.29 info
Change: +$6.28 (+79%) info
Market Cap: $3.659B info